Assessment tools for chemotherapy-induced peripheral neuropathy: a narrative review of clinician, patient-reported, and objective measures
Tool selection should align with the specific needs of clinicians and researchers. Instruments that are valid, reliable, and assess multiple CIPN domains are recommended. Further research is needed to validate many of these tools in CIPN-specific populations and to determine their MCIDs.
Authors
- Kaitlin Chen (ORCID: https://orcid.org/0000-0003-3911-9087)
- Е. Г. Антонен
- Jennifer Michelle Jones (ORCID: https://orcid.org/0000-0002-8670-8514)
- Michelle B. Nadler (ORCID: https://orcid.org/0000-0002-4372-3204)
- Emma Mauti
Institutions
- University of Toronto (CA)
- Toronto Rehabilitation Institute (CA)
- Princess Margaret Cancer Centre (CA)
Publication Details
- Journal
- JNCI Cancer Spectrum
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1093/jncics/pkaf119
- Citations
- 1
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 1.05